Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,181 | -19,479 | -16,702 | -12,838 | -18,838 |
| Depreciation Amortization | 1,114 | 1,351 | 1,351 | 374 | 369 |
| Income taxes - deferred | N/A | N/A | N/A | -1,302 | -556 |
| Accounts receivable | -467 | N/A | N/A | N/A | N/A |
| Other Working Capital | -874 | -2,189 | -480 | -457 | 653 |
| Other Operating Activity | 4,138 | 4,735 | 5,204 | 5,031 | 7,766 |
| Operating Cash Flow | $-18,270 | $-15,582 | $-10,627 | $-9,192 | $-10,606 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -824 | -131 | -810 | -58 | -279 |
| Net Acquisitions | N/A | 3,008 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -3,392 | N/A | N/A |
| Sale Of Investment | N/A | N/A | 13,016 | N/A | N/A |
| Investing Cash Flow | $-824 | $2,877 | $8,814 | $-58 | $-279 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 717 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -815 | -100 |
| Common Stock Issued | 23,061 | 9,975 | N/A | 9,486 | 7,579 |
| Dividend Paid | N/A | N/A | N/A | N/A | -80 |
| Other Financing Activity | -568 | -1,000 | 0 | 0 | -173 |
| Financing Cash Flow | $23,210 | $8,975 | $N/A | $8,671 | $7,226 |
| Beginning Cash Position | 6,733 | 10,463 | 12,276 | 5,711 | 9,370 |
| End Cash Position | 10,849 | 6,733 | 10,463 | 5,132 | 5,711 |
| Net Cash Flow | $4,116 | $-3,730 | $-1,813 | $-579 | $-3,659 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,270 | -15,582 | -10,627 | -9,192 | -10,606 |
| Capital Expenditure | -824 | -224 | -875 | -58 | -279 |
| Free Cash Flow | -19,094 | -15,806 | -11,502 | -9,250 | -10,885 |